WO2004099428A1 - Extraction method of beta glucan from phellinus linteus through cell destruction and enzyme fermentation method - Google Patents
Extraction method of beta glucan from phellinus linteus through cell destruction and enzyme fermentation method Download PDFInfo
- Publication number
- WO2004099428A1 WO2004099428A1 PCT/KR2004/001055 KR2004001055W WO2004099428A1 WO 2004099428 A1 WO2004099428 A1 WO 2004099428A1 KR 2004001055 W KR2004001055 W KR 2004001055W WO 2004099428 A1 WO2004099428 A1 WO 2004099428A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phellinus linteus
- glucan
- extraction
- mixture
- phellinus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- E—FIXED CONSTRUCTIONS
- E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
- E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
- E06B9/00—Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
- E06B9/24—Screens or other constructions affording protection against light, especially against sunshine; Similar screens for privacy or appearance; Slat blinds
- E06B9/26—Lamellar or like blinds, e.g. venetian blinds
- E06B9/36—Lamellar or like blinds, e.g. venetian blinds with vertical lamellae ; Supporting rails therefor
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- E—FIXED CONSTRUCTIONS
- E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
- E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
- E06B9/00—Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
- E06B9/24—Screens or other constructions affording protection against light, especially against sunshine; Similar screens for privacy or appearance; Slat blinds
- E06B9/26—Lamellar or like blinds, e.g. venetian blinds
- E06B9/38—Other details
- E06B9/386—Details of lamellae
Definitions
- the present invention relates to a method for efficiently extracting and isolating ⁇ -glucan from Phellinus linteus in high yield.
- Phellinus species are very rare perennial mushrooms in nature which grow on mulberry and broadleaved trees in the high reaches, and several tens of species have been identified to date.
- Representative Phellinus spp. are Phellinus linteus and Phellinus baumi which mainly grow on the trunk of mulberry and broadleaved trees. According to a recent report, Phellinus linteus which has been allowed only as a medical raw material can be used as a raw material for foods (see, an article from the Korean daily economic newspaper dated February 7, 2003).
- Phellinus linteus contains a large quantity of nutrients beneficial to humans, such as potassium, calcium, magnesium, vitamin B2, B3 and C, fibroid materials, amino acids and the like, and in particular, ⁇ - glucan, which is a polysaccharide substance.
- ⁇ -glucan is a medicinal and therapeutically active ingredient.
- the fact that ⁇ -glucan has immunopotentiating effects and anticancer effects is found in many related literatures and Korean traditional herb medical books, including Dongeuibogam, Sinnongbonchogyeong and Hyangyakjipsungbang.
- Phellinus linteus has inhibitory effects against viruses, bacteria, fungi and parasites, inhibitory effects against tumors (cancers) at an inhibition level of 96.7%, and antioxidant effects against oxygen radicals and free radicals through immunopotentiating mechanisms.
- ⁇ -glucan contained in Phellinus linteus is present in cell walls in a protein-bound state, and is surrounded by a large amount of water-insoluble fibroid materials.
- Phellinus linteus includes fruiting bodies composed of a number of hard and thick cell layers. Korean Patent Laid-open No.
- 2003-30636 discloses a method for producing a protein-polysaccharide by adding an organic substance and an organic nutrient to the fruiting bodies of a mushroom to obtain a fermentation mixture, inoculating the mixture with the mycelia of the ⁇ basidiomycetes or yeast, followed by fermentation, hot-water extraction, dialysis, centrifugation and lyophilization.
- the texture of the fruiting bodies is softened by fermentation so that the extraction of the protein-polysaccharide is facilitated and thus the protein-polysaccharide is produced in high yield.
- other fermentation metabolites as well as ingredients inherent to the mushroom are generated, it is difficult to collect functional ingredients of the mushroom in the natural state.
- the hard fruiting bodies are finely pulverized, they are too large in size to be used as substrates of an enzyme generated during fermentation by the inoculated mycelia of the basidiomycetes or yeast.
- the fruiting bodies are highly insoluble, it is almost impossible to collect ⁇ -glucan present in the cell walls on a large scale.
- the fruiting bodies contain impurities other than ⁇ -glucan.
- Korean Patent No. 308392 discloses a method for producing an extract of natural Phellinus linteus by mixing pulverized - Phellinus linteus with a solvent, and boiling the mixture in a heating bath under reduced pressure. At this time, the mixture is subjected to super high frequency sonication for 24 hours in order to increase the extraction efficiency.
- This method requires a long time for extraction, and uses an organic solvent such as 1,3-butylene chloride, propyleneglycol or isopropanol as an extracting solvent. Accordingly, the method is improper to separate highly polar ⁇ -glucan present in the cell walls on a large scale and to extract inherent ingredients of Phellinus linteus.
- an organic solvent such as 1,3-butylene chloride, propyleneglycol or isopropanol
- Phellinus linteus is an expensive oriental herb costing as much as hundreds or thousands of U.S. dollars per kg
- the hot- water extraction must be reconsidered because it is uneconomical.
- the medicinal ⁇ -glucan is present in hard cell layers and is a highly water-insoluble macromolecule having a molecular weight on the order of 1,000,000 daltons. Since the quantification of the macromolecular ⁇ - • glucan has not been sufficiently investigated, the simple hot- water extraction must be reconsidered under this situation.
- Figs. 1 to 5 are optical microscope images (1250x) showing changes in the morphology of the fruiting bodies of Phellinus linteus powders and residues obtained after extraction and centrifugation of the Phellinus linteus powders, which are obtained in Example 1 and Comparative Examples 1 and 2 of the present invention.
- Fig. 1 is an optical microscope image of Phelinus Linteus
- Fig. 2 is an optical microscope image of pulverized Phellinus linteus
- Fig. 3 is an optical microscope image of ultrasonically pulverized Phellinus linteus
- Fig. 4 is an optical microscope image of hot-water treated Phellinus linteus under high pressure
- Fig. 5 is an optical microscope image of enzyme-treated Phellinus linteus.
- the present invention has been made in view of the above problems, and it is an object of the present invention to provide a method for efficiently extracting and isolating ⁇ -glucan and other medically effective ingredients from Phellinus linteus.
- the Phellinus linteus is subjected to sonication and the hard cell layers are degraded under high pressure hot-water extraction conditions, thereby forming a condition under which protease and cellulase can function, hi addition, since the content of soluble ingredients is determined by a dry process, the total extraction efficiency can be measured.
- the extraction efficiency of ⁇ -glucan can be quantitatively determined by an ultrafiltration method using the molecular size of ⁇ -glucan.
- a method for extracting medically effective ingredients from Phellinus linteus comprising the steps of: adding a pulverized Phellinus linteus powder into a distilled water of an amount ranging from 20 to 50 times based on the weight of the powder to make a mixture, and ultrasonicating the mixture; extracting the mixture with hot- water under a pressure of 2 to 3 atm, and filtering the extract through a membrane filter to obtain a filtrate; and enzyme-reacting the filtrate with cellulase and alkalase and subjecting to ultrafiltration on a membrane filter.
- Phellinus linteus according to the present invention is very economical and quantitative. According to the method of the present invention, medically effective ingredients of expensive Phellinus linteus can be utilized in the various industrial fields such as pharmaceuticals, cosmetics and foods in an economic and efficient manner.
- Comparative Example 1 Hot- water extraction of samples and ultrafiltration lOg of each of Phellinus linteus powder was extracted with about 300ml of distilled water at 100°C for 1, 2, 3 and 4 hours, followed by centrifugation. The resulting supernatant was concentrated with heating to a volume of 15ml. 5ml of the concentrate was separately dried to obtain a dry extract. The dry extract was weighed, and the result was multiplied by three. The obtained value was used as an extraction rate of the total dry extract. The results are summarized in Table 1 below. The remaining 10ml of the concentrate was subjected to ultrafiltration on a membrane filter having a pore size of 7,000 MWCO (Molecular Weight Cut Off).
- Comparative Example 2 Hot- water extraction of samples under high pressure and ultrafiltration
- Example 1 Ultrasonic hot-water extraction of samples under high pressure and ultrafiltration
- Example 1 Determination of content of crude ⁇ -glucan in dry extract prepared in Example 1
- the content of crude ⁇ -glucan in the dry extracts prepared in Example 1 was determined in accordance with methods of Mannors, D. J. (1973, The structure of a ⁇ -(l,6)-D-glucan, from yeast cell walls. Biochem. J. 135, 19-30) and Catley, B. J. (1988. Isolation and analysis of cell walls Yeast (A practical approach). IRL press, pp. 163-183).
- the content of crude ⁇ -glucan in the dry extracts was determined by measuring the glucose content in glucan fractions obtained through chemical treatment using a NaOH solution.
- Figs. 1 to 5 are optical microscope images (1250x) showing changes in the morphology of the fruiting bodies of the Phellinus linteus powders and the residues obtained after extraction and centrifugation of the Phellinus linteus powders, which were obtained in Example 1 and Comparative Examples 1 and 2.
- Fig. 1 is an optical microscope image of Phelinus Linteus
- Fig. 2 is an optical microscope image of the pulverized Phellinus linteus
- Fig. 3 is an optical microscope image of the ultrasonically pulverized Phellinus linteus
- Fig. 4 is an optical microscope image of the hot-water treated Phellinus linteus under high pressure
- Fig. 5 is an optical microscope image of the enzyme-treated Phellinus linteus.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Structural Engineering (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Civil Engineering (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Architecture (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Disclosed herein is a method for extracting and isolating crude β-glucan as a medically effective ingredient from Phellinus linteus in high yield. Specifically, the method increases the extraction rate of crude β-glucan from Phellinus linteus through degradation of the fruiting bodies of Phellinus linteus by sonication, destruction of cell walls using hot-water under high pressure, and enzyme fermentation.
Description
EXTRACTION METHOD OF BETA GLUCAN FROM PHELLINUS LINTEUS THROUGH CELL DESTRUCTION AND ENZYME FERMENTATION METHOD
Technical Field
The present invention relates to a method for efficiently extracting and isolating β-glucan from Phellinus linteus in high yield.
Background Art
Phellinus species are very rare perennial mushrooms in nature which grow on mulberry and broadleaved trees in the high reaches, and several tens of species have been identified to date. Representative Phellinus spp. are Phellinus linteus and Phellinus baumi which mainly grow on the trunk of mulberry and broadleaved trees. According to a recent report, Phellinus linteus which has been allowed only as a medical raw material can be used as a raw material for foods (see, an article from the Korean daily economic newspaper dated February 7, 2003). Like common mushrooms, Phellinus linteus contains a large quantity of nutrients beneficial to humans, such as potassium, calcium, magnesium, vitamin B2, B3 and C, fibroid materials, amino acids and the like, and in particular, β- glucan, which is a polysaccharide substance. β-glucan is a medicinal and therapeutically active ingredient. The fact that β-glucan has immunopotentiating effects and anticancer effects is found in many related literatures and Korean traditional herb medical books, including Dongeuibogam, Sinnongbonchogyeong and Hyangyakjipsungbang. Recent studies have revealed that Phellinus linteus has inhibitory effects against viruses, bacteria, fungi and parasites, inhibitory effects against tumors (cancers) at an inhibition level of 96.7%, and antioxidant effects against oxygen radicals and free radicals through immunopotentiating mechanisms. β-glucan contained in Phellinus linteus is present in cell walls in a protein-bound state, and is surrounded by a large amount of water-insoluble fibroid materials. Phellinus linteus includes fruiting bodies composed of a number of hard and thick cell layers.
Korean Patent Laid-open No. 2003-30636 (published on April 18, 2003) discloses a method for producing a protein-polysaccharide by adding an organic substance and an organic nutrient to the fruiting bodies of a mushroom to obtain a fermentation mixture, inoculating the mixture with the mycelia of the ■ basidiomycetes or yeast, followed by fermentation, hot-water extraction, dialysis, centrifugation and lyophilization.
According to this method, the texture of the fruiting bodies is softened by fermentation so that the extraction of the protein-polysaccharide is facilitated and thus the protein-polysaccharide is produced in high yield. However, since other fermentation metabolites as well as ingredients inherent to the mushroom are generated, it is difficult to collect functional ingredients of the mushroom in the natural state. Although the hard fruiting bodies are finely pulverized, they are too large in size to be used as substrates of an enzyme generated during fermentation by the inoculated mycelia of the basidiomycetes or yeast. In addition, since the fruiting bodies are highly insoluble, it is almost impossible to collect β-glucan present in the cell walls on a large scale. Furthermore, the fruiting bodies contain impurities other than β-glucan.
Korean Patent No. 308392 (published on August 28, 2001) discloses a method for producing an extract of natural Phellinus linteus by mixing pulverized - Phellinus linteus with a solvent, and boiling the mixture in a heating bath under reduced pressure. At this time, the mixture is subjected to super high frequency sonication for 24 hours in order to increase the extraction efficiency.
This method requires a long time for extraction, and uses an organic solvent such as 1,3-butylene chloride, propyleneglycol or isopropanol as an extracting solvent. Accordingly, the method is improper to separate highly polar β-glucan present in the cell walls on a large scale and to extract inherent ingredients of Phellinus linteus.
On the other hand, only 5~12% of ingredients of Phellinus linteus are extracted by hot-water extraction, and the remainder are not used. Considering that Phellinus linteus is an expensive oriental herb costing as much as hundreds or thousands of U.S. dollars per kg, the hot- water extraction must be reconsidered because it is uneconomical. The medicinal β-glucan is present in hard cell layers and is a highly water-insoluble macromolecule having a molecular weight on the order of 1,000,000 daltons. Since the quantification of the macromolecular β- • glucan has not been sufficiently investigated, the simple hot- water extraction must
be reconsidered under this situation.
A number of studies on maximizing the extraction efficiency of medicinal ingredients, particularly β-glucan, from expensive Phellinus linteus are being actively undertaken. These studies seem to contribute to decreased economic burden to patients as a medicinal and edible material, and induction of scientific clinical results.
Brief Description the Drawings
The above and other objects, features and other advantages of the present invention will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
Figs. 1 to 5 are optical microscope images (1250x) showing changes in the morphology of the fruiting bodies of Phellinus linteus powders and residues obtained after extraction and centrifugation of the Phellinus linteus powders, which are obtained in Example 1 and Comparative Examples 1 and 2 of the present invention.
Specifically, Fig. 1 is an optical microscope image of Phelinus Linteus; Fig. 2 is an optical microscope image of pulverized Phellinus linteus; Fig. 3 is an optical microscope image of ultrasonically pulverized Phellinus linteus; Fig. 4 is an optical microscope image of hot-water treated Phellinus linteus under high pressure; and Fig. 5 is an optical microscope image of enzyme-treated Phellinus linteus.
Disclosure of the Invention
Technical Solution
The present invention has been made in view of the above problems, and it is an object of the present invention to provide a method for efficiently extracting and isolating β-glucan and other medically effective ingredients from Phellinus linteus. In the method of the present invention, the Phellinus linteus is subjected to sonication and the hard cell layers are degraded under high pressure hot-water extraction conditions, thereby forming a condition under which protease and cellulase can function, hi addition, since the content of soluble ingredients
is determined by a dry process, the total extraction efficiency can be measured. Furthermore, the extraction efficiency of β-glucan can be quantitatively determined by an ultrafiltration method using the molecular size of β-glucan.
In order to accomplish the above object of the present invention, there is provided a method for extracting medically effective ingredients from Phellinus linteus, comprising the steps of: adding a pulverized Phellinus linteus powder into a distilled water of an amount ranging from 20 to 50 times based on the weight of the powder to make a mixture, and ultrasonicating the mixture; extracting the mixture with hot- water under a pressure of 2 to 3 atm, and filtering the extract through a membrane filter to obtain a filtrate; and enzyme-reacting the filtrate with cellulase and alkalase and subjecting to ultrafiltration on a membrane filter.
Advantageous effects
As apparent from the above description, the method for extracting
Phellinus linteus according to the present invention is very economical and quantitative. According to the method of the present invention, medically effective ingredients of expensive Phellinus linteus can be utilized in the various industrial fields such as pharmaceuticals, cosmetics and foods in an economic and efficient manner.
Although the preferred embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the invention as disclosed in the accompanying claims.
Best Mode for Carrying Out the Invention
The present invention will now be described in more detail with reference to the following examples. However, these examples are given for the purpose of illustration and are not to be construed as limiting the scope of the invention.
Comparative Example 1: Hot- water extraction of samples and
ultrafiltration lOg of each of Phellinus linteus powder was extracted with about 300ml of distilled water at 100°C for 1, 2, 3 and 4 hours, followed by centrifugation. The resulting supernatant was concentrated with heating to a volume of 15ml. 5ml of the concentrate was separately dried to obtain a dry extract. The dry extract was weighed, and the result was multiplied by three. The obtained value was used as an extraction rate of the total dry extract. The results are summarized in Table 1 below. The remaining 10ml of the concentrate was subjected to ultrafiltration on a membrane filter having a pore size of 7,000 MWCO (Molecular Weight Cut Off). After 10ml of a phosphate buffer (pH 5.8) was added to the filtrate and dissolved, 1.2mg of cellulase (Fluka 22180 0.3 U/mg) was added thereto. The mixture was cultured at 60°C for one day. After the mixture was adjusted to pH 9.0 by addition of a potassium phosphate solution, it was subjected to an enzyme reaction with cellulose and 1ml of alkalase was added thereto. The resulting mixture was cultured at 60°C for one day. The obtained culture was subjected to ultrafiltration on a membrane filter having a pore size of 7,000 MWCO (Molecular Weight Cut Off). The obtained filtrate was concentrated. About 1ml of the resulting supernatant was again subjected to ultrafiltration using 20ml of distilled water. The obtained filtrate was concentrated. 1ml of the resulting supernatant was dried under reduced pressure to afford crude β-glucan as a dark brown solid. The crude β-glucan was weighed and the result was multiplied by 1.5. The obtained value was used as an extraction rate of the crude β-glucan. The results are summarized in Table 1 below.
Table 1
About 300ml of distilled water was added to lOg of each of Phellinus linteus powder, and each mixture was extracted under 2 atm and at 120°C for 1, 2, 3 and 4 hours. The following procedure was carried out in the same manner as in Comparative Example 1. The results are summarized in Table 2 below.
Table 2
10. Example 1: Ultrasonic hot-water extraction of samples under high pressure and ultrafiltration
About 300ml of distilled water was added to lOg of each of Phellinus linteus powder, and each mixture was subjected to ultrasonic irradiation using a Power 6, Sonifier Cell Disrupter 350 manufactured by Branson Sonic Power Co.
15 for 10, 20, 30 and 60 minutes. Thereafter, the extraction was performed under 2 atm at 120°C for 3 hours. The following procedure was carried out in the same manner as in Comparative Example 1. The results are summarized in Table 3 below.
20 Table 3
As can be seen from the extraction conditions and extraction rates of crude β-glucan in Phellinus linteus shown in Tables 1 to 3, the maximum extraction rate (34.6%) of the total dry extract and the maximum extraction rate (5.2%o) of crude β-glucan in Example 1 (a combination of ultrasonic extraction for degradation of fruiting bodies and hot-water extraction under high pressure) were higher than those in Comparative Example 1 (hot-water extraction) and Comparative Example 2 (hot-water extraction under high pressure). From these results, the extraction rate of the total dry extract and the extraction rate of crude β-glucan having anticancer activities in Example 1 are 5 and 12 times as high as those in the hot-water extraction, respectively.
Determination of content of crude β-glucan in dry extract prepared in Example 1 The content of crude β-glucan in the dry extracts prepared in Example 1 was determined in accordance with methods of Mannors, D. J. (1973, The structure of a β-(l,6)-D-glucan, from yeast cell walls. Biochem. J. 135, 19-30) and Catley, B. J. (1988. Isolation and analysis of cell walls Yeast (A practical approach). IRL press, pp. 163-183). In the present invention, the content of crude β-glucan in the dry extracts was determined by measuring the glucose content in glucan fractions obtained through chemical treatment using a NaOH solution.
Referring to Figs. 1 to 5, changes in the morphology of Phellinus linteus according to the respective steps are shown. That is, Figs. 1 to 5 are optical microscope images (1250x) showing changes in the morphology of the fruiting bodies of the Phellinus linteus powders and the residues obtained after extraction and centrifugation of the Phellinus linteus powders, which were obtained in Example 1 and Comparative Examples 1 and 2. Specifically, Fig. 1 is an optical microscope image of Phelinus Linteus; Fig. 2 is an optical microscope image of the pulverized Phellinus linteus; Fig. 3 is an optical microscope image of the ultrasonically pulverized Phellinus linteus; Fig. 4 is an optical microscope image of the hot-water treated Phellinus linteus under high pressure; and Fig. 5 is an optical microscope image of the enzyme-treated Phellinus linteus.
From Figs. 1 to 5, it was confirmed that as the steps were proceeded, the
fruiting bodies of Phellinus linteus were sufficiently loosened so as to be easy to extract.
Claims
1. A method of extracting medically effective ingredients from Phellinus linteus, comprising the steps of: adding a pulverized Phellinus linteus powder into a distilled water of an amount ranging from 20 to 50 times based on the weight of the powder to make a mixture, and ultrasonicating the mixture; extracting the mixture with hot-water under a pressure of 2 to 3 atm, and filtering the extract through a membrane filter to obtain a filtrate; and enzyme-reacting the filtrate with cellulase and alkalase and subjecting to ultrafiltration on a membrane filter.
2. The method according to claim 1, wherein the medically effective ingredient is crude β-glucan.
3. A composition comprising medically effective ingredients exfracted by the method according to claim 1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020030028783A KR20040096000A (en) | 2003-05-07 | 2003-05-07 | Extraction method of beta Glucan from Phellinus Linteus through cell destruction and enzyme fermentation method |
| KR10-2003-0028783 | 2003-05-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004099428A1 true WO2004099428A1 (en) | 2004-11-18 |
Family
ID=33432414
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2003/001723 Ceased WO2004099427A1 (en) | 2003-05-07 | 2003-08-26 | Method of extracting crude beta glucan from phellinus linteus |
| PCT/KR2004/001055 Ceased WO2004099428A1 (en) | 2003-05-07 | 2004-05-06 | Extraction method of beta glucan from phellinus linteus through cell destruction and enzyme fermentation method |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2003/001723 Ceased WO2004099427A1 (en) | 2003-05-07 | 2003-08-26 | Method of extracting crude beta glucan from phellinus linteus |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR20040096000A (en) |
| AU (1) | AU2003256111A1 (en) |
| WO (2) | WO2004099427A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104592409A (en) * | 2015-01-12 | 2015-05-06 | 陕西师范大学 | Method for extracting high-activity phellinus linteus polysaccharide at low pressure and low temperature |
| CN106749734A (en) * | 2016-12-26 | 2017-05-31 | 庆阳敦博科技发展有限公司 | sweet lily polysaccharide extracting method |
| KR101879506B1 (en) * | 2016-10-05 | 2018-07-17 | 경북대학교 산학협력단 | Extracting method of beta-glucan from Phellinus baumii |
| US10323263B2 (en) | 2015-02-03 | 2019-06-18 | Tate & Lyle Sweden Ab | Methods for producing liquid compositions comprising β-glucan |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100825396B1 (en) * | 2007-02-28 | 2008-04-29 | 주식회사 한불후치피아 | Method for Extracting Water-Soluble Liquid Components from Animal and Plant Organisms |
| KR100908034B1 (en) * | 2007-06-18 | 2009-07-20 | 계명대학교 산학협력단 | Mushroom extract, jelly and kochujang containing it |
| KR100981347B1 (en) * | 2007-11-23 | 2010-09-10 | 강원대학교산학협력단 | Bokbunja Extract Method |
| KR101477140B1 (en) * | 2012-11-13 | 2014-12-29 | 한국식품연구원 | Production method of? -glucan |
| KR101687985B1 (en) | 2015-08-27 | 2016-12-23 | 주식회사 엔에스텍 | Extraction of Beta Glucan from Mushrooms Using Subcritical Extraction |
| CN109369818A (en) * | 2018-10-12 | 2019-02-22 | 齐鲁工业大学 | Method for extracting eucalyptus xylan by ultrasonic co-cooking method |
| CN111635916A (en) * | 2020-06-28 | 2020-09-08 | 上海应用技术大学 | A kind of pretreatment method for yeast β-glucan extraction |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11318432A (en) * | 1998-04-30 | 1999-11-24 | Korea Advanced Inst Of Sci Technol | Immune-enhancing active polysaccharide material isolated from a novel Perinus strain and its use |
| KR100303886B1 (en) * | 1994-11-19 | 2001-11-22 | 임곤혁 | Method for extracting anticancer component from phellinus linteus |
| JP2002171936A (en) * | 2000-12-05 | 2002-06-18 | Yukito Akiyama | Health food and method for producing the same |
| KR20030072417A (en) * | 2002-03-04 | 2003-09-15 | 박홍제 | Manufacture method of a functional tea and food, using extract of mushroom mycelium by new extraction technique. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002000229A (en) * | 2000-06-23 | 2002-01-08 | S F C:Kk | Health food |
| JP2002262820A (en) * | 2001-03-07 | 2002-09-17 | Isao Horiuchi | Method for extracting active ingredient of mushrooms |
| JP2003183176A (en) * | 2001-10-09 | 2003-07-03 | Wellness Movement:Kk | Immunostimulatory composition |
-
2003
- 2003-05-07 KR KR1020030028783A patent/KR20040096000A/en not_active Ceased
- 2003-08-26 WO PCT/KR2003/001723 patent/WO2004099427A1/en not_active Ceased
- 2003-08-26 AU AU2003256111A patent/AU2003256111A1/en not_active Abandoned
-
2004
- 2004-05-06 WO PCT/KR2004/001055 patent/WO2004099428A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100303886B1 (en) * | 1994-11-19 | 2001-11-22 | 임곤혁 | Method for extracting anticancer component from phellinus linteus |
| JPH11318432A (en) * | 1998-04-30 | 1999-11-24 | Korea Advanced Inst Of Sci Technol | Immune-enhancing active polysaccharide material isolated from a novel Perinus strain and its use |
| JP2002171936A (en) * | 2000-12-05 | 2002-06-18 | Yukito Akiyama | Health food and method for producing the same |
| KR20030072417A (en) * | 2002-03-04 | 2003-09-15 | 박홍제 | Manufacture method of a functional tea and food, using extract of mushroom mycelium by new extraction technique. |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104592409A (en) * | 2015-01-12 | 2015-05-06 | 陕西师范大学 | Method for extracting high-activity phellinus linteus polysaccharide at low pressure and low temperature |
| US10323263B2 (en) | 2015-02-03 | 2019-06-18 | Tate & Lyle Sweden Ab | Methods for producing liquid compositions comprising β-glucan |
| KR101879506B1 (en) * | 2016-10-05 | 2018-07-17 | 경북대학교 산학협력단 | Extracting method of beta-glucan from Phellinus baumii |
| CN106749734A (en) * | 2016-12-26 | 2017-05-31 | 庆阳敦博科技发展有限公司 | sweet lily polysaccharide extracting method |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004099427A1 (en) | 2004-11-18 |
| KR20040096000A (en) | 2004-11-16 |
| AU2003256111A1 (en) | 2004-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9249438B2 (en) | Production of fungal extracellular immune stimulating compounds | |
| CN109939027B (en) | Method for preparing ergothioneine-containing cosmetic stock solution by fermenting hericium erinaceus | |
| JP2004514403A (en) | Method for producing glucuronoxylomannan as a nutritional supplement from higher basidiomycete mushrooms and composition thereof | |
| JP2002262820A (en) | Method for extracting active ingredient of mushrooms | |
| CN103271951B (en) | Method for preparing cordyceps preparations with high adenosine contents | |
| US6090615A (en) | Method for extracting a Basidiomycetes mycelium-containing culture medium using β-1,3-glucanase | |
| WO2004099428A1 (en) | Extraction method of beta glucan from phellinus linteus through cell destruction and enzyme fermentation method | |
| JPH01228480A (en) | Production of extract of cultured mycelia of edible basidiomycete | |
| HK1249366A1 (en) | Method for producing fermented bamboo extract and immunostimulator | |
| JP2011236183A (en) | Method for extracting ergosterol peroxide derived from mushrooms | |
| CN103421861B (en) | The method of Cordyceps Polysaccharide produced by a kind of liquid state fermentation rice bran wheat bran complete feed | |
| Kumla et al. | Research advances in fungal polysaccharides: production, extraction, characterization, properties, and their multifaceted applications | |
| US6120772A (en) | Oral drugs for treating AIDS patients | |
| KR100936176B1 (en) | Red Duck Mushrooms (Leatiporussulphureus var. Iiiitus) Extracellular polysaccharides having antidiabetic activity derived from mycelial culture medium and preparation method thereof | |
| KR100706132B1 (en) | Media composition for culturing Felinus linteus mycelium | |
| KR20060116463A (en) | Mushroom Mycelium with Ginseng Facquet Medium and Its Production Method | |
| CN1228449C (en) | Ganoderma mycellium antitumour water soluble neteropolysaccharide and its preparation method and use | |
| JP2908357B2 (en) | Method for extracting useful components from mycelium-containing medium | |
| JPH09234086A (en) | Extraction of useful component from mycelium-containing medium | |
| KR0143512B1 (en) | Immunopotentive agents and isolating methods from cultivated ganoderma lucidum | |
| CN108795770B (en) | Solid state culture method for increasing polysaccharide content in inonotus obliquus | |
| CN103272213A (en) | Cordyceps militaris protein extract and antitumor application thereof | |
| KR101735433B1 (en) | Culture method for increasing the amount of basidiomycete mycelium and polysaccharide | |
| CN103285042B (en) | Black fungus protein extract and anti-tumor application thereof | |
| JP4705434B2 (en) | Anticancer agent and method for producing anticancer agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase |